Semnur Pharmaceuticals Begins Pivotal Phase 3 Trial For SP-102 In Patients With Lumbar Radicular Pain/Sciatica

January 7, 2018

Responsive image

MOUNTAIN VIEW, Calif., Jan. 7, 2018 /PRNewswire/ — Semnur Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company focused on developing and commercializing novel therapeutics for pain, announced the start of a pivotal Phase 3 clinical trial in the U.S. to evaluate its…

Category: Precious Metals